In British Columbia the number is lower, 15%. In Quebec, 62% of new drugs are approved and are on the market. Numbers like 15% or 21%, depending on the province, are lower than the numbers approved in Quebec, in terms of new drugs available to patients. One of your goals is to make these drugs more accessible to the public. That is why I am asking you this question.
Do you deny these numbers? Do you think they are realistic? You have not improved the process for approving and marketing some drugs for patients. You defend your role, but the effectiveness of your role is somewhat questionable.